Matt Collins, IV, has extensive experience in the pharmaceutical industry, currently serving as Vice President of US Contracts, Operations and Reporting at Takeda since January 2014. Previously, Matt held roles at Shire Pharmaceuticals, including Senior Director and Director of Government Pricing and Reporting, where responsibilities included contract operations and government pricing management. Prior to Shire, Matt worked at Ernst & Young as a Manager, focusing on compliance audits for pharmaceutical pricing calculations. Early in their career, Matt contributed to Merck in various analytical roles and supported clinical research at GlaxoSmithKline. Matt holds an MBA in Organizational Management from Eastern University and a Bachelor of Science in Chemical Engineering from Drexel University.